| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Oct―02 |
Intelligent computing framework to analyze the transmission risk of COVID-19: Meyer wavelet artificial neural networks |
Kottakkaran Sooppy Nisar, Iqra Naz, Muhammad Asif Zahoor Raja, Muhammad Shoaib |
| 2 |
[GO] |
2024―Jun―29 |
DIFFERENTIAL EPITOPE PREDICTION ACROSS DIVERSE CIRCULATING VARIANTS OF SARS-COV-2 IN BRAZIL |
Vanessa de Melo Cavalcanti Dantas, Brenda Fernandes, Pedro Henrique Lopes Ferreira Dantas, Glaucielle Ramalho Uchoa, Andrei Félix Mendes, Waldecir Oliveira de Araújo Júnior, Lúcio Roberto Cançado Castellano, Ana Isabel Vieira Fernandes, Luiz Ricardo Goulart Filho, Renato Antônio dos Santos Oliveira, Priscilla Anne Castro de Assis, Joelma Rodrigues De Souza, Clarice Neuenschwander Lins de Morais |
| 3 |
[GO] |
2024―Jun―24 |
Exploring the Binding Dynamics of Covalent Inhibitors within Active Site of PLpro in SARS-CoV-2 |
Deepesh Kumar Patel, Harish Kumar, M. Elizabeth Sobhia |
| 4 |
[GO] |
2024―Apr―02 |
K1K2NN: A novel multi-label classification approach based on neighbors for predicting COVID-19 drug side effects |
Pranab Das, Dilwar Hussain Mazumder |
| 5 |
[GO] |
2023―Sep―21 |
A Bioinformatic Analysis: Previous allergen exposure may support anti- SARS-CoV-2 immune response |
Işil Kutluturk Karagoz, Mucahit Kaya, René Rückert, Nazli Bozman, Vildan Kaya, Halim Bayram, Mustafa Yildirim |
| 6 |
[GO] |
2023―Sep―20 |
Computational analysis of substrate recognition of Sars-Cov-2 Mpro main protease |
Hilal Sena Tasci, Ebru Akkus, Muslum Yildiz, Abdulkadir Kocak |
| 7 |
[GO] |
2023―Sep―09 |
COMPUTATIONAL ANALYSIS OF THE INTERACTIONS BETWEEN EBSELEN AND DERIVATIVES WITH THE ACTIVE SITE OF THE MAIN PROTEASE FROM SARS-COV-2 |
Guilherme Schmitt Rieder, Pablo Andrei Nogara, Folorunsho Bright Omage, Tâmie Duarte, Cristiane Lenz Dalla Corte, João Batista Teixeira da Rocha |
| 8 |
[GO] |
2023―Aug―16 |
A Deep-SIQRV Epidemic Model for COVID-19 to Access the Impact of Prevention and Control Measures |
Aakansha Gupta, Rahul Katarya |
| 9 |
[GO] |
2023―Jul―19 |
ReGen-DTI: A novel generative drug target interaction model for predicting potential drug candidates against SARS-COV2 |
Kaushik Bhargav Sivangi, Santhosh Amilpur, Chandra Mohan Dasari |
| 10 |
[GO] |
2023―Jul―07 |
Role of Molecular Mimicry in the SARS-CoV-2-Human Interactome for Pathogenesis of Cardiovascular Disease: An Update to ImitateDB |
Sonali Tayal, Sonika Bhatnagar |
| 11 |
[GO] |
2023―Jul―06 |
Terpenoid phytocompounds from mangrove plant Xylocarpus moluccensis as possible inhibitors against SARS-CoV-2: In silico strategy |
Kiran Bharat Lokhande, Arti Kale, Bhagyashree Shahakar, Ashish Shrivastava, Neelu Nawani, K. Venkateswara Swamy, Ashutosh Singh, Sarika Vishnu Pawar |
| 12 |
[GO] |
2023―May―24 |
Inflammation Inhibitory Activity of Green Tea, Soybean, and Guava Extracts During Sars-Cov-2 Infection Through TNF Protein in Cytokine Storm |
Didik Priyandoko, Wahyu Widowati, Hanna Sari Widya Kusuma, Ervi Afifah, Cahyaning Rizki Wijayanti, Rizal Rizal, Ika Adhani Sholihah, Galuh Wening Permatasari, Anggia Ramadhani, Didik Huswo Utomo |
| 13 |
[GO] |
2023―Jan―05 |
QM/MM study of N501 involved intermolecular interaction between SARS-CoV-2 receptor binding domain and antibody of human origin |
Yuemin Liu, Hana F. Sulaiman, Bruce R. Johnson, Rulong Ma, Yunxiang Gao, Harshica Fernando, Ananda Amarasekara, Andrea Ashley-Oyewole, Huajun Fan, Heaven N. Ingram, James M. Briggs |
| 14 |
[GO] |
2023―Jan―03 |
Extraction of Knowledge Graph of Covid-19 Through Mining of Unstructured Biomedical Corpora |
Sudhakaran Gajendran, D Manjula, Vijayan Sugumaran, R Hema |
| 15 |
[GO] |
2022―Sep―07 |
Dual Computational and Biological Assessment of Some Promising Nucleoside Analogs against the COVID-19-Omicron Variant |
Mohnad Abdalla, Amgad M. Rabie |
| 16 |
[GO] |
2022―Aug―18 |
Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants |
Daniel Melo de Oliveira Campos, Maria Karolaynne da Silva, Emmanuel Duarte Barbosa, Chiuan Yee Leow, Umberto Laino Fulco, Jonas Ivan Nobre Oliveira |
| 17 |
[GO] |
2022―Jun―28 |
A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2 |
Ekampreet Singh, Rajat Kumar Jha, Rameez Jabeer Khan, Ankit Kumar, Monika Jain, Jayaraman Muthukumaran, Amit Kumar Singh |
| 18 |
[GO] |
2022―May―14 |
Interaction of the New Inhibitor Paxlovid (PF-07321332) and Ivermectin With the Monomer of the Main Protease SARS-CoV-2: A Volumetric Study Based on Molecular Dynamics, Elastic Networks, Classical Thermodynamics and SPT |
Ysaias José Alvarado, Yosmari Olivarez, Carla Lossada, Joan Vera-Villalobos, José Luis Paz, Eddy Vera, Marcos Loroño, Alejandro Vivas, Fernando Javier Torres, Laura N. Jeffreys, María Laura Hurtado-León, Lenin González-Paz |
| 19 |
[GO] |
2022―May―11 |
A multilevel approach for screening natural compounds as an antiviral agent for COVID-19 |
Mahdi Vasighi, Julia Romanova, Miroslava Nedyalkova |
| 20 |
[GO] |
2022―Apr―30 |
A new approach for determining SARS-CoV-2 epitopes using machine learning-based in silico methods |
Pınar Cihan, Zeynep Banu Ozger |
| 21 |
[GO] |
2022―Apr―29 |
Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains |
Premnath Madanagopal, Harshini Muthukumar, Kothai Thiruvengadam |
| 22 |
[GO] |
2022―Apr―09 |
A Composite Ranking of Risk Factors for COVID-19 Time-To-Event Data from a Turkish Cohort |
Ayse Ulgen, Sirin Cetin, Meryem Cetin, Hakan Sivgin, Wentian Li |
| 23 |
[GO] |
2022―Apr―06 |
Mathematical modeling and analysis of the SARS-Cov-2 disease with reinfection |
Asghar Atifa, Muhammad Altaf Khan, Kulpash Iskakova, Fuad S. Al-Duais, Irshad Ahmad |
| 24 |
[GO] |
2022―Mar―28 |
SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis |
Lucas Prescott |
| 25 |
[GO] |
2022―Mar―23 |
Glycosylation is key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2 |
Georcki Ropón-Palacios, Jhon Pérez-Silva, Ricardo Rojas-Humpire, Gustavo E. Olivos-Ramírez, Manuel Chenet-Zuta, Victor Cornejo-Villanueva, Sheyla Carmen-Sifuentes, Kewin Otazu, Yaritza L. Ramirez-Díaz, Karolyn Vega Chozo, Ihosvany Camps |
| 26 |
[GO] |
2022―Feb―26 |
Design and various in silico studies of the novel curcumin derivatives as potential candidates against COVID-19 -associated main enzymes |
Hakan Alici, Hakan Tahtaci, Kadir Demir |
| 27 |
[GO] |
2022―Feb―26 |
Machine learning prediction of 3CLpro SARS-CoV-2 docking scores |
Lukas Bucinsky, Dušan Bortňák, Marián Gall, Ján Matúška, Viktor Milata, Michal Pitoňák, Marek Štekláč, Daniel Végh, Dávid Zajaček |
| 28 |
[GO] |
2022―Feb―19 |
A Global Report on the Dynamics of COVID-19 with Quarantine and Hospitalization: A Fractional Order Model with Non-Local Kernel |
Zubair Ahmad, Sherif A. El-Kafrawy, Thamir A. Alandijany, Francesco Giannino, Ahmed A. Mirza, Mai M. El-Daly, Arwa A. Faizo, Leena H. Bajrai, Mohammad Amjad Kamal, Esam I. Azhar |
| 29 |
[GO] |
2021―Dec―01 |
Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk |
Ping Chen, Jingfang Wang, Xintian Xu, Yuping Li, Yan Zhu, Xuan Li, Ming Li, Pei Hao |
| 30 |
[GO] |
2021―Nov―20 |
SARS-CoV-2: Can sunlight exposure reduce the risk of developing severe consequences of COVID-19? |
Jibran Sualeh Muhammad, Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
| 31 |
[GO] |
2021―Nov―02 |
Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic |
Lifei Ma, Huiyang Li, Jinping Lan, Xiuqing Hao, Huiying Liu, Xiaoman Wang, Yong Huang |
| 32 |
[GO] |
2021―Oct―26 |
Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein |
Archana Pal, Shefali Dobhal, Kishore Kumar Dey, Anish Kumar Sharma, Vivek Savani, Vishal Singh Negi |
| 33 |
[GO] |
2021―Sep―02 |
Potential Achilles heels of SARS-CoV-2 are best displayed by the base order-dependent component of RNA folding energy |
Chiyu Zhang, Donald R. Forsdyke |
| 34 |
[GO] |
2021―Jul―30 |
Modelling the spread of covid-19 in the capital of Brazil using numerical solution and cellular automata |
André Luís Brasil Cavalcante, Lucas Parreira de Faria Borges, Moisés Antônio da Costa Lemos, Márcio Muniz de Farias, Hervaldo Sampaio Carvalho |
| 35 |
[GO] |
2021―Jul―05 |
Efficient Machine Learning Model for Predicting Drug-Target Interactions with Case Study for Covid-19 |
Heba El-Behery, Abdel-Fattah Attia, Nawal El-Feshawy, Hanaa Torkey |
| 36 |
[GO] |
2021―Jun―19 |
A computational analysis of molecular evolution for virulence genes of zoonotic novel coronavirus (COVID-19) |
Priya Kumari, Raju Poddar |
| 37 |
[GO] |
2021―Jun―18 |
Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak |
Avizit Das, Sarah Khurshid, Aleya Ferdausi, Eshita Sadhak Nipu, Amit Das, Fee Faysal Ahmed |
| 38 |
[GO] |
2021―May―06 |
Designing Potential siRNA Molecule for the Nucleocapsid(N) Gene Silencing of Different SARS-CoV-2 Strains of Bangladesh: Computational Approach |
Syed Shahariar Bappy, Abu Zaffar Shibly, Sorna Sultana, A.K.M. Mohiuddin, Yearul Kabir |
| 39 |
[GO] |
2021―Mar―29 |
Exploring the effectiveness of the TSR-based protein 3-D structural comparison method for protein clustering, and structural motif identification and discovery of protein kinases, hydrolase, and SARS-CoV-2’s protein via the application of amino acid grouping |
Titli Sarkar, Vijay V. Raghavan, Feng Chen, Andrew Riley, Sophia Zhou, Wu Xu |
| 40 |
[GO] |
2021―Feb―21 |
Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 MPro by targeting the cysteine 145 |
Laurent Soulère, Thibaut Barbier, Yves Queneau |
| 41 |
[GO] |
2020―Nov―05 |
Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism |
Md. Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md. Niaz Morshed, Dolilur Rahman, Saeed Anwar, Mohammad Jakir Hosen |
| 42 |
[GO] |
2020―Oct―23 |
Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay |
Eleni Pitsillou, Julia Liang, Chris Karagiannis, Katherine Ververis, Kevion K. Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis |
| 43 |
[GO] |
2020―Sep―13 |
Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease |
Muhammad Usman Mirza, Sarfraz Ahmad, Iskandar Abdullah, Matheus Froeyen |
| 44 |
[GO] |
2020―Sep―06 |
Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface |
Julia Liang, Chris Karagiannis, Eleni Pitsillou, Kevion K. Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis |
| 45 |
[GO] |
2020―Aug―01 |
An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2 |
Abhijit Sarma, Homen Phukan, Neha Halder, Madathiparambil Gopalakrishnan Madanan |
| 46 |
[GO] |
2020―Jul―31 |
Repurposing approved Drugs as potential Inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and Structure Based Drug Design |
Franz-Josef Meyer-Almes |
| 47 |
[GO] |
2020―Jun―25 |
Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors |
Alicia Jiménez-Alberto, Rosa María Ribas-Aparicio, Gerardo Aparicio-Ozores, Juan A. Castelán-Vega |
| 48 |
[GO] |
2020―May―28 |
Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex |
Julia Liang, Eleni Pitsillou, Chris Karagiannis, Kevion K Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis |
